Citations

Clear

13603 citation(s) found for "_, _".

Correction: Activation of PI3K/Akt/mTOR signaling in the tumor stroma drives endocrine therapy-dependent breast tumor regression
Polo, María Laura, Riggio, Marina, May, María , Rodriguez, María Jimena , Perrone, María Cecilia , Kaen, Diego, Frost, Marlene H., Stallings-Mann, Melody, Frost, Marlene, Boughey, Judy, Radisky, Derek, Polo, María L. , Stallings‐Mann, Melody , Goetz, Matthew P. , Boughey, Judy C. , Lanari, Claudia , Radisky, Derek C. , Novaro, Virginia

Mayo Clinic

Oncotarget | May 20, 2025 | Volume: 16 | Issue: 1 | Pages: 379-381

10.18632/oncotarget.28728 | PMID 40391748 Get It

Associations between neck circumference, obstructive sleep apnea, and arterial stiffness in older adults
Brutto, Óscar H. Del , Mera, Robertino M. , Costa, Aldo F. , Rumbea, Denisse A. , Arias, Emilio E. , Brutto, Víctor J. Del , Del Brutto, Oscar H , Del Brutto, Victor J , Rumbea, Denisse A , Castillo, Pablo R.

Mayo Clinic

Vascular Medicine | May 20, 2025 | Volume: 30 | Issue: 4 | Pages: 482-484

10.1177/1358863x251334144 | PMID 40391654 Get It

A multicenter, prospective, single‐arm study of 60‐day peripheral nerve stimulation of the occipital nerves for the treatment of headache
Gutierrez, Genaro, McCormick, Zachary L. , Engle, Mitchell, Gilmore, Christopher A , Pingree, Matthew J. , Pope, Jason E. , DiBenedetto, David , Kissoon, Narayan , Sayal, Puneet, Zurn, Claire A. , Boggs, Joseph W. , DiBenedetto, David J , Kissoon, Narayan R , Crosby, Nathan D , Boggs, Joseph W , Pingree, Matthew , McCormick, Zachary L , Crosby, Nathan D.

Mayo Clinic

Headache: The Journal of Head and Face Pain | May 20, 2025 | Volume: 65 | Issue: 10 | Pages: 1776-1787

10.1111/head.14948 | PMID 40391557 Get It

Abstract Objective The aim of this study was to evaluate the efficacy and safety of a 60‐day peripheral nerve stimulation (PNS) treatment targeting the occipital nerves for reducing pain and improving function in individuals diagnosed with cervicogenic headache or occipital neuralgia. Background Headache conditions are prevalent and commonly disabling, and conventional therapeutic strategies are often insufficient. Development of a percutaneous 60‐day PNS treatment has created new opportunities to evaluate PNS of the occipital nerves. Methods This study was an institutional review board‐approved, multicenter, prospective, single‐arm study that enrolled participants from October 2022 to March 2024. Participants with cervicogenic headache or occipital neuralgia received a 60‐day PNS treatment targeting the occipital nerves. The primary endpoint was the proportion reporting clinically significant (≥30%) reductions in average pain and/or pain interference at end of treatment (EOT). Additional analysis included the proportion of participants with ≥50% reduction in average pain intensity and/or pain interference and additional outcomes including Patient Global Impression of Change, six‐item Headache Impact Test, and Neck Disability Index. Results At EOT, 90% of participants (18/20) met the primary endpoint. Further, 85% (17/20) and 83% (15/18) reported ≥50% reductions in pain and/or pain interference at EOT and 3 months, respectively. Clinically meaningful improvements were observed in functional and headache‐related disability and quality‐of‐life measures. All study‐related adverse events were non‐serious. Conclusion Most participants reported significant reductions in pain and/or pain interference following 60‐day PNS targeting the occipital nerves. Outcomes through 3 months demonstrate how 60‐day PNS offers an effective approach for the treatment of headache.
A Scoping Review of Interventions to Promote Diversity, Equity, and Inclusion in the United States Healthcare Workforce
Hill, Katherine A. , Austin, Andrew, Austin, Andrew W, Hill, Katherine Ann , Enders, Felicity

Mayo Clinic

Journal of Medical Education and Curricular Development | May 19, 2025 | Volume: 12 | Issue: No issue available | Pages: No page available

10.1177/23821205251333034 | PMID 40395665 Get It

Background Diversifying the healthcare workforce is critical to achieving a healthier, more equitable society. Objectives The objective of this literature review was to examine and synthesize the literature on interventions to promote diversity, equity, and inclusion (DEI) in people who are currently enrolled in the workforce or in a terminal degree/training program and who are located in the following institution types: medical centers; healthcare organizations; and schools of dentistry, medicine, nursing, nurse practitioners, physician assistants, and public health. Methods A literature search was performed on November 2, 2023 in Ovid MEDLINE ® . We reviewed titles and abstracts of all retrieved articles from 2000 forward and the full text of articles included in the final review. We included English-language articles published in peer-reviewed journals that detailed 1 or more interventions to promote DEI in the United States and United States territories. All data included in the final review was extracted by a single investigator and charted using an Excel spreadsheet. Results The authors identified 55 articles for inclusion, 4 of which aggregated and analyzed data from many interventions. The remainder detailed 52 interventions across 25 states and Puerto Rico. Most articles did not include a comparison group (38, 69%). The types of interventions identified were: institutional change (14, 27%), mentorship (13, 25%), development programs (13, 25%), pathway programs (5, 10%), financial support (2, 4%), and workshops (2, 4%). Three (6%) interventions could not be categorized. Most studies detailed interventions in medicine (28, 54%) and nursing (11, 21%), focused on racial and ethnic (42, 81%) and/or sex (12, 23%) diversity, and targeted students (33, 64%) and/or faculty/staff (28, 54%). Conclusion Many different types of interventions have been trialed to promote workforce DEI in the United States healthcare workforce. These efforts must continue to achieve a diverse and equitable healthcare workforce.
The International Classification of Vestibular Disorders: Achievements, challenges, and future directions
Kaski, Diego , Tarnutzer, Alexander A. , Carey, John P. , Cha, Yoon‐Hee , Eggers, Scott D.Z. , Furman, Joseph M. , Kim, Hyun Ah , Lempert, Thomas , López‐Escámez, José A. , Magnusson, Måns , Newman‐Toker, David E. , Seemungal, Barry M. , Berg, Raymond van de , Brevern, Michael von , Bisdorff, Alexandre , Cha, Y H , Eggers, Scott Dz, Lempert, Thomas , López-Escámez, Jose A , Magnusson, Mans , Newman-Toker, David E , Seemungal, Barry M , Staab, Jeffrey P , Agrawal, Yuri , Kim, Ji‐Soo , Staab, Jeffrey P. , Strupp, Michael Leo , Ward, Bryan Kevin

Mayo Clinic

Journal of Vestibular Research | May 17, 2025 | Volume: 35 | Issue: 3 | Pages: 105-112

10.1177/09574271251313803 | PMID 39973600 Get It

In 2007, the Bárány Society embarked on a project to establish definitions of vestibular syndromes and disorders based on best available evidence, referred to as the International Classification of Vestibular Disorders (ICVD). Since then, numerous publications providing consensus-driven diagnostic criteria for vestibular symptoms, syndromes, and disorders have been published. Here, we reflect on the rationale for developing the ICVD as well as its subsequent achievements, challenges, and outlook. In this summary of the work of the ICVD to date, the authors will focus on practical aspects to help improve the utility and applicability of these diagnostic criteria moving forward.
Cerebrovascular Vasospasms, Cerebral Sinus Venous Thrombosis, and Rapid Empyema Reaccumulation in a Child with a Coinfection of Fusobacterium nucleatum and Prevotella loescheii
Geiser, Rachel , Zorio, Onilia, Appavu, Brian

Mayo Clinic

Journal of Child Neurology | May 16, 2025 | Volume: 40 | Issue: 7 | Pages: 563-565

10.1177/08830738251339048 | PMID 40375808 Get It

Fusobacterium nucleatum and Prevotella loescheii are anaerobic gram-negative rods that exist in the oral cavity. To our knowledge, pediatric central nervous system complications with these pathogens have not been well described. An 11-year-old previously healthy vaccinated female child presented for 2 weeks of sinusitis that progressed to left arm and leg hemiplegia. Initial neuroimaging demonstrated a superior sagittal sinus thrombosis and a right hemispheric subdural empyema with midline shift, necessitating surgical evacuation. Culture of the subdural accumulation demonstrated coinfection of Fusobacterium nucleatum and Prevotella loescheii . Within 24 hours of evacuation, the patient progressed to have right hemispheric electrographic status epilepticus, with neuroimaging demonstrating reaccumulation of the empyema and a moderate right middle cerebral artery vasospasm. Transcranial doppler ultrasonography of the right middle cerebral artery territory demonstrated mean flow velocities up to 148 cm/s with a Lindengaard ratio of 3.44. The patient underwent repeat subdural evacuation and was managed with intravenous fluids, permissive hypertension, oral nimodipine, and intravenous milrinone. Electrographic status epilepticus was treated with intravenous lacosamide and levetiracetam. Repeat neuroimaging demonstrated improvement in subdural collection size and resolution of vasospasms. She was discharged after 16 days with continued lacosamide and levetiracetam for seizures, and enoxaparin (Lovenox) for the superior sagittal sinus thrombosis. We present a novel pediatric case of Fusobacterium nucleatum and Prevotella loescheii manifesting with rapid subdural empyema reaccumulation after surgical evacuation, status epilepticus, cerebrovascular vasospasms, and cerebral sinus venous thrombosis. Further work is needed to understand the potential neurologic complications of this condition.
Epidemiology, Incidence of Infection, and Antibiotic Use in Pediatric Traumatic Ear Lacerations
Pazelli, Alexandre Meira, Gates-Tanzer, Lauren, Willborg, Brooke E. , Srikumar, Jainaha K. , Bite, Uldis, Gibreel, Waleed , Meira Pazelli, Alexandre, Gibreel, Waleed , Mardini, Samir , Sharaf, Basel

Mayo Clinic

Annals of Plastic Surgery | May 15, 2025 | Volume: 94 | Issue: 6 | Pages: 653-657

10.1097/sap.0000000000004325 | PMID 40358961 Get It

Background The management and use of antibiotics in pediatric ear lacerations lacks standardization. This study sought to provide a comprehensive review of these injuries and assess the impact of administering perioperative antibiotics on the incidence of infections after repair. Methods Retrospective review of all pediatric ear lacerations treated at our institution's emergency department (ED) between 1998 and 2024. Results A total of 246 patients (177 boys) were included. Patients aged 0–6 years were most affected (n = 117, 47.6%), with the peak between 2–5 years old (n = 78, 31.7%). Most lacerations were superficial (n = 145, 58.9%), followed by intermediate (n = 62, 25.2%), full thickness (n = 34, 13.9%), and split earlobe defects (n = 5, 2%). Most of the patients (n = 110, 54.7%) were managed by emergency medicine providers. Plastic and reconstructive surgery (n = 34, 16.9%) and otorhinolaryngology (n = 32, 15.9%) consultations were obtained when the lacerations affected cartilage (P < 0.001). Surgical repair included primary closure in 203 (82.5%), with 179 (88.2%) performed under local/topical anesthesia in the ED. Of patients with cartilage lacerations (n = 61), 48 had cartilage repair. Eight patients had preoperative intravenous antibiotics, while 105 (42.7%) received postoperative prophylactic oral antibiotics. Among those with intermediate and full-thickness injuries (n = 96), 67.7% were discharged on prophylactic oral antibiotics. Only 1 case of surgical site infection occurred in a patient with a superficial laceration. Conclusions Pediatric ear lacerations mostly affect boys aged 2–5 years and are usually repaired under local anesthesia in the ED. The incidence of infection is low, and the routine prescription of prophylactic oral antibiotics appears to have a limited impact on the overall incidence of surgical site infection. Further studies are needed to validate these findings.
The Mutational Landscape in Polycythemia Vera: Phenotype, Genotype, and Prognostic Correlates
Rana, Masooma , Iftikhar, Moazah, Jadoon, Yamna, Abdelmagid, Maymona, Viswanatha, David S., He, Rong , Reichard, Kaaren K. , Pardanani, Animesh , Gangat, Naseema , Tefferi, Ayalew , Pardanani, Animesh

Mayo Clinic

American Journal of Hematology | May 15, 2025 | Volume: 100 | Issue: 8 | Pages: 1343-1353

10.1002/ajh.27717 | PMID 40372079 Get It

ABSTRACTPolycythemia vera (PV) is invariably associated with a JAK2 mutation, with over 50% of patients harboring additional non‐JAK2 mutations. In the current study, 319 patients with PV underwent NGS at diagnosis or in chronic phase PV (Group A: N = 270, 85%) or at the time of fibrotic (Group B; N = 37, 12%) or leukemic (Group C; N = 12, 4%) transformation. Mutational frequencies involving TP53/SRSF2/IDH1/U2AF1 were significantly (p < 0.05) different between patients in the mutually exclusive Groups A (2%/4%/2%/0.4%), B (8%/0%/0%/5%), and C (50%/25%/17%/8%). Analyses on phenotype/genotype associations and prognostic impact on overall (OS), leukemia‐free (LFS), and myelofibrosis‐free (MFFS) survival were limited to Group A patients. ASXL1MUT was associated with younger age (p < 0.01), SRSF2MUT with older age and leukocytosis (p < 0.01), and TP53MUT with leukocytosis (p < 0.01). Mutation co‐segregation was apparent between ASXL1 and IDH2 (p < 0.01) or SRSF2 (p < 0.01), SRSF2 and IDH2 (p < 0.01), and TP53 and NRAS (p = 0.01). Multivariable analysis identified SRSF2MUT (p < 0.01; HR, 4.2, 1.9–9.5), IDH2MUT (p = 0.01; HR, 5.3, 1.8–15.3), ASXL1MUT (p = 0.04; HR, 2.0, 1.1–3.7), leukocyte count ≥ 15 × 109/L (p < 0.01; HR 2.0, 1.3–3.1), and advanced age (p < 0.01) as risk factors for OS. Median OS in the presence (N = 235; 87%) or absence (N = 35; 13%) of any adverse mutation (i.e., SRSF2MUT, ASXL1MUT, or IDH2MUT) was 8.8 versus 17.8 years (p = 0.01; HR 1.8, 1.1–2.9). In addition, ASXL1MUT (p = 0.02; HR, 1.6–24.9), SRSF2MUT (p = 0.06; HR, 11.9, 1.1–126.2), and advanced age (p = 0.04) were associated with inferior LFS, and SRSF2MUT (p < 0.01; HR, 24.0, 5.5–103.8) and abnormal karyotype (p < 0.01; HR 3.8, 1.6–8.9) with inferior MFFS. The number of non‐JAK2 mutations was significant in predicting outcome in univariate but not multivariable analysis. The observations from the current study highlight the prognostic significance of non‐JAK2 mutations in PV and the prospect of their inclusion in future prognostic models.
Expert Strategies: Skull Base Reconstruction—Global Perspectives, Insights, and Algorithms through a Mixed Methods Approach
Talati, Vidit , Patel, Jagatkumar A. , Nguyen, Theodore V. , Pang, Jonathan C. , Liu, Lauren , Craig, John R. , Papagiannopoulos, Peter , Phillips, Katie M. , Tajudeen, Bobby A. , Adappa, Nithin D. , Sedaghat, Ahmad R. , Anand, Vijay K. , Batra, Pete S., Bergsneider, Marvin, Casiano, Roy R. , Cavallo, Luigi Maria , Cohen, Marc A. , Eloy, Jean Anderson , Evans, James J., Fernandez‐Miranda, Juan C. , Ferrari, Marco , Froelich, Sébastien , Gardner, Paul A. , Gray, Stacey T. , Hanna, Ehab Y., Harvey, Richard J. , Hong, Sang Duk , Hwang, Peter H. , Kong, Doo‐Sik , Lan, Ming‐Ying , Lee, John Y. K. , Levine, Corinna G. , Meço, Cem , Nicolai, Piero, Nyquist, Gurston , Omura, Kazuhiro , Patel, Zara M. , Celda, María Peris, Prevedello, Danny M., Rabinowitz, Mindy, Raza, Shaan M., Sargi, Zoukaa , Schlosser, Rodney J. , Schwartz, Theodore H. , Sindwani, Raj , Stamm, Aldo Cassol , Thorp, Brian D. , Wang, Marilene B. , Wang, Wei‐Hsin , Witterick, Ian , Won, Tae‐Bin , Woodworth, Bradford A. , Wormald, Peter‐John, Zada, Gabriel , Su, Shirley Y. , Kuan, Edward C , Talati, Vidit , Nguyen, Theodore V , Pang, Jonathan C , Craig, John R , Sedaghat, Ahmad R , Wang, Eric W , Ferrari, Marco , Georgalas, Christos , Harvey, Richard J , Hwang, Peter H , Lan, Ming-Ying , Omura, Kazuhiro , Patel, Zara , Neto, Carlos Pinheiro, Schlosser, Rodney J , Snyderman, Carl H , Woodworth, Bradford A , Meço, Cem , Su, Shirley Y , Abiri, Arash , Goshtasbi, Khodayar , Adappa, Nithin D. , Bergsneider, Marvin , Bernal‐Sprekelsen, Manuel , Bleier, Benjamin S. , Cappabianca, Paolo , Carrau, Ricardo L. , Castelnuovo, Paolo , Dallan, Iacopo , El‐Sayed, Ivan H. , Hanna, Ehab Y., Kelly, Daniel F. , Liu, James K. , Locatelli, Davide , McKean, Erin L. , Nicolai, Piero , Passeri, Thibault , Pinheiro‐Neto, Carlos , Prevedello, Danny M., Recinos, Pablo F. , Rosen, Marc R , Turri‐Zanoni, Mario , Wormald, Peter‐John

Mayo Clinic

International Forum of Allergy & Rhinology | May 15, 2025 | Volume: 15 | Issue: 10 | Pages: 1032-1069

10.1002/alr.23596 | PMID 40371737 Get It

ABSTRACT Objective There is limited consensus on endoscopic skull base surgery (ESBS) reconstruction principles. This study aims to generate comprehensive themes regarding ESBS reconstruction by pooling the experiences of ESBS experts, with comparison to a literature review of current published evidence. Methods Structured qualitative interviews of ESBS experts regarding postoperative management and reconstruction of various defect locations were conducted. Results A total of 68 experts comprising 40 academic teams across 13 countries with an average of 18 years of ESBS experience were included. We propose 10 stepwise algorithms for common skull base reconstruction scenarios based on these expert interviews. When available, the nasoseptal flap is used for all high_flow cerebrospinal leak defects. Multilayered reconstruction is favored at all anatomical subsites with increasing number of layers for increasing defect size and complexity. Heterogeneity exists in terms of inlay technique and materials, free grafting versus various pedicled flap options for low‐flow defects or in the absence of a nasal septum, nasal packing, tissue sealant, lumbar drain use, and postoperative management. Commonalities and discrepancies between experts were summarized. Conclusion Skull base reconstruction and post‐ESBS management is highly complex with a wide variety of practice patterns and expert strategies. Further research of higher quality evidence is warranted to identify optimal management patterns, though the current work aims to inform surgeons on these controversial areas by drawing from numerous experiences.
Characterizing Disease Severity, Comorbidities, and Treatment Plans in Pediatric Hidradenitis Suppurativa Patients With and Without Obesity: A Cohort and Cross‐Sectional Analysis
Numani, Asfia , Ziebart, Rachel, Aghazadeh, Nessa , Davis, Dawn Marie R. , Davis, Dawn M R , Numani, Asfia , Aghazadeh Mohandesi, Nessa , Todd, Austin W. , Alavi, Afsáneh

Mayo Clinic

Pediatric Dermatology | May 15, 2025 | Volume: 42 | Issue: 4 | Pages: 773-778

10.1111/pde.15983 | PMID 40371736 Get It

ABSTRACTBackgroundHidradenitis suppurativa (HS) is a chronic inflammatory condition. While obesity is linked to increased HS severity in adults, data on its impact in pediatric HS remain limited. This study investigates the relationships between obesity, HS severity, HS‐related comorbidities, and therapeutic management in pediatric patients.MethodsThis is a retrospective cohort analysis on patients diagnosed with HS before 18 years of age. Data were collected on disease severity, comorbidity development, and treatments. Trends were compared between HS patients with and without obesity and with healthy controls for comorbidity development.ResultsThere was no difference in disease severity using Hurley staging between patients with and without obesity (p = 0.679). Patients with obesity were more likely to be prescribed biologics (p = 0.012), but not other treatments. The risk of developing dyslipidemia, anxiety, depression, and thyroid disease was elevated in pediatric HS patients, even after controlling for BMI (p < 0.001).ConclusionsIn this study, obesity was not associated with HS disease severity in children. However, children with obesity were more likely to be prescribed biologics. HS may independently increase the risk of dyslipidemia, anxiety, depression, and thyroid disease.